Jeffrey L Jorgensen

13PUBLICATIONS
58CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursLiquid biopsiesHaematologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 27, 2026
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.

|Feb 20, 2026
Mature T-cell leukemia/lymphoma with an NK-like immunophenotype: A report of 7 cases.

Wei J Wang, Sa A Wang, Hong Fang

|Aug 15, 2025
Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype.

Wei J Wang, Sa A Wang, Hong Fang

|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia.

Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian

|Oct 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission.

Elias Jabbour, Fadi G Haddad, Nicholas J Short

|Aug 22, 2023
Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection.

Sa A Wang, Jeffrey L Jorgensen, Shimin Hu

Pageof 3

Frequent Collaborators

5 joint publications

Hong Fang

4 joint publications

Farhad Ravandi

4 joint publications

Sa A Wang

3 joint publications

Wei Wang